Clinical trials: Coronary Artery Ectasia

Kawasaki Disease, Coronary Aneurysm

Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease

• Active, not recruiting
• Age: 1 month to 21 years
• Phase 2
• Results posted

Kawasaki disease (KD) affects infants and young children causing inflammation of the skin and blood vessels including the coronary arteries of the heart.

Trial name

NCT01917721

Testing

Doxycycline

Where

United States

Volunteers

26 people

Sponsor

Hawaii Pacific Health